Pemetrexed (AlimtaR, LY231514) demonstrates clinical activity in chemonaive patients with cervical cancer in a phase II single-agent trial
- 1 May 2006
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 16 (3) , 1172-1178
- https://doi.org/10.1111/j.1525-1438.2006.00451.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Topotecan in Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology GroupGynecologic Oncology, 2000
- Evaluation of Gemcitabine in Patients with Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology GroupGynecologic Oncology, 2000
- Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group StudyEuropean Journal Of Cancer, 2000
- Irinotecan in cancers of the lung and cervixAnti-Cancer Drugs, 1999
- Improved Treatment for Cervical Cancer — Concurrent Chemotherapy and RadiotherapyNew England Journal of Medicine, 1999
- A Phase II Study of Prolonged Oral Etoposide in Advanced or Recurrent Carcinoma of the CervixGynecologic Oncology, 1998
- Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix.Journal of Clinical Oncology, 1998
- Cancer of the Uterine CervixNew England Journal of Medicine, 1996
- Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase ii study of the gynecologic oncology groupCancer, 1981
- The effect of combined treatment with a platinum complex and ionizing radiation on chinese hamster ovary cells in vitroBritish Journal of Cancer, 1976